Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.
暂无分享,去创建一个
E. Henry | W. Eaton | R. Best | Emily B. Dunkelberger | S. Thein | H. Bunn | Troy Cellmer | B. Metaferia | Anna K Conrey | Quan Li | Julia Harper | Kristen E. Glass | Anna K. Conrey
[1] E. Henry,et al. MWC allosteric model explains unusual hemoglobin-oxygen binding curves from sickle cell drug binding , 2021, Biophysical journal.
[2] K. Ataga,et al. Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. , 2021, The Lancet. Haematology.
[3] Roger M. Howard,et al. PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease. , 2020, Journal of medicinal chemistry.
[4] L. Kiger,et al. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease , 2020 .
[5] E. Henry,et al. Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease , 2020, Proceedings of the National Academy of Sciences.
[6] D. K. Wood,et al. High-throughput assessment of hemoglobin polymer in single red blood cells from sickle cell patients under controlled oxygen tension , 2019, Proceedings of the National Academy of Sciences.
[7] W. Eaton. Hemoglobin S polymerization and sickle cell disease: A retrospective on the occasion of the 70th anniversary of Pauling's Science paper , 2019, American journal of hematology.
[8] K. Ataga,et al. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. , 2019, The New England journal of medicine.
[9] M. Steinberg. Primary polymerization prevention. , 2019, Blood.
[10] J. Nichols,et al. Voxelotor treatment of a patient with sickle cell disease and very severe anemia , 2019, American journal of hematology.
[11] E. Henry,et al. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia. , 2019, Bioconjugate chemistry.
[12] Jeff F Dunn,et al. Partial pressure of oxygen in the human body: a general review. , 2019, American journal of blood research.
[13] G. Mann,et al. Defining Physiological Normoxia for Improved Translation of Cell Physiology to Animal Models and Humans. , 2019, Physiological reviews.
[14] E. Henry,et al. Theoretical Simulation of Red Cell Sickling Upon Deoxygenation Based on the Physical Chemistry of Sickle Hemoglobin Fiber Formation. , 2018, The journal of physical chemistry. B.
[15] R. Hebbel,et al. Sickle hemoglobin oxygen affinity‐shifting strategies have unequal cerebrovascular risks , 2018, American journal of hematology.
[16] W. Eaton,et al. Treating sickle cell disease by targeting HbS polymerization. , 2017, Blood.
[17] E. Henry,et al. Kinetic assay shows that increasing red cell volume could be a treatment for sickle cell disease , 2017, Proceedings of the National Academy of Sciences.
[18] G. Kato,et al. New developments in anti‐sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo? , 2016, British journal of haematology.
[19] F. Ferrone. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half‐life in a murine model of sickle cell disease , 2016, British journal of haematology.
[20] W. Eaton,et al. Universality of supersaturation in protein-fiber formation , 2016, Nature Structural &Molecular Biology.
[21] E. Henry,et al. Experiments on Hemoglobin in Single Crystals and Silica Gels Distinguish among Allosteric Models. , 2015, Biophysical journal.
[22] Ethan Schonbrun,et al. Single-cell measurement of red blood cell oxygen affinity , 2015, Proceedings of the National Academy of Sciences.
[23] A. Mozzarelli,et al. Identification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte Sickling , 2014, ACS chemical biology.
[24] C. Kieda,et al. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia , 2011, Journal of cellular and molecular medicine.
[25] William,et al. Delay Time of Gelation : A Possible Determinant of Clinical Severity in Sickle Cell Disease , 2005 .
[26] C. R. Taylor,et al. Estimating transit time for capillary blood in selected muscles of exercising animals , 1992, Pflügers Archiv.
[27] Andrea Mozzarelli,et al. Is cooperative oxygen binding by hemoglobin really understood? , 1999, Nature Structural Biology.
[28] D. J. Harrington,et al. The high resolution crystal structure of deoxyhemoglobin S. , 1997, Journal of molecular biology.
[29] A. Schechter,et al. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Edelstein,et al. Double strand packing in hemoglobin S fibers. , 1993, Journal of molecular biology.
[31] D. Abraham,et al. Vanillin, a potential agent for the treatment of sickle cell anemia. , 1991, Blood.
[32] J. Hofrichter,et al. Sickle cell hemoglobin polymerization. , 1990, Advances in protein chemistry.
[33] J. Hofrichter,et al. Hemoglobin S gelation and sickle cell disease. , 1987, Blood.
[34] J. Hofrichter,et al. Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. , 1987, Science.
[35] H. Bunn,et al. Hemoglobin: Molecular, Genetic and Clinical Aspects , 1984 .
[36] M. Perutz,et al. Physiological and x-ray studies of potential antisickling agents. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Hofrichter,et al. Oxygen binding by sickle cell hemoglobin polymers. , 1982, Journal of molecular biology.
[38] A. Deyoung,et al. Oxygen binding to sickle cell hemoglobin. , 1981, Methods in enzymology.
[39] R. Edalji,et al. Solubilization of hemoglobin S by other hemoglobins. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Labie,et al. Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Hofrichter,et al. Thermodynamics of gelation of sickle cell deoxyhemoglobin. , 1977, Journal of molecular biology.
[42] A. Minton,et al. Analysis of non-ideal behavior in concentrated hemoglobin solutions. , 1977, Journal of molecular biology.
[43] M. Goldberg,et al. Participation of hemoglobins A and F in polymerization of sickle hemoglobin. , 1977, The Journal of biological chemistry.
[44] R. Pittman,et al. Effects of altered carbon dioxide tension on hemoglobin oxygenation in hamster cheek pouch microvessels. , 1977, Microvascular research.
[45] A. Minton. Non-ideality and the thermodynamics of sickle-cell hemoglobin gelation. , 1977, Journal of molecular biology.
[46] J. Hofrichter,et al. Supersaturation in sickle cell hemoglobin solutions. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[47] K. B. Ward,et al. Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution. , 1975, Journal of molecular biology.
[48] E. Beutler. The effect of carbon monoxide on red cell life span in sickle cell disease. , 1975, Blood.
[49] J. Hofrichter,et al. Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[50] Q. Gibson. Organic phosphates and ligand binding in hemoglobin. , 1970, Biochemical and biophysical research communications.
[51] J. Bertles,et al. Hemoglobin Interaction: Modification of Solid Phase Composition in the Sickling Phenomenon , 1970, Science.
[52] Q. Gibson. The reaction of oxygen with hemoglobin and the kinetic basis of the effect of salt on binding of oxygen. , 1970, Journal of Biological Chemistry.
[53] H. Bunn,et al. The interaction of 2,3-diphosphoglycerate with various human hemoglobins. , 1970, The Journal of clinical investigation.
[54] J. Changeux,et al. ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. , 1965, Journal of molecular biology.
[55] E. Beutler. The effect of methemoglobin formation in sickle cell disease. , 1961, Journal of Clinical Investigation.
[56] H. Hartridge,et al. The kinetics of hæmoglobin. III.—The velocity with which oxygen combines with reduced hæmoglobin , 1925 .
[57] H. Hartridge,et al. The Kinetics of Haemoglobin. III.--The Velocity with which Oxygen Combines with Reduced Haemoglobin , 1925 .
[58] H. Hartridge,et al. The Kinetics of Haemoglobin. II. The Velocity with Which Oxygen Dissociates from Its Combination with Haemoglobin , 1923 .
[59] Christian Bohr,et al. Ueber einen in biologischer Beziehung wichtigen Einfluss, den die Kohlensäurespannung des Blutes auf dessen Sauerstoffbindung übt1 , 1904 .